Hereditary hemochromatosis: Population screening based on phenotype in Brazilian blood donors

Journal of Clinical Gastroenterology

Volumn 39, Issue 5, 2005, Pages 430-434

  Bastos Dias Barbosa, Kátia Valéria ^a,b   Meirelles De Souza, Aécio Flávio ^a   Chebli, Júlio Maria Fonseca ^a   Proietti, Fernando Augusto ^b   Portes Meirelles, Ricardo Souza ^a   De Souza, Juliano Leite ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b Postgrad Ctr of Fed Univ of MG   (Brazil)

Author keywords

Epidemiology; Hereditary hemochromatosis; Phenotype; Screening

Indexed keywords

FERRITIN; TRANSFERRIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BRAZIL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ETHNOLOGY; FEMALE; FERRITIN BLOOD LEVEL; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS; HOMOZYGOTE; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MORBIDITY; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SEX ROLE; TRANSFERRIN BLOOD LEVEL;

ADOLESCENT; ADULT; BLOOD DONORS; BRAZIL; CHILD; DNA; FEMALE; FERRITINS; GENE FREQUENCY; GENETIC MARKERS; GENETIC SCREENING; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; TRANSFERRIN;

EID: 17444375358     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000159218.85537.e5     Document Type: Article

References (22)

1. Pietrangelo A. EASL International Consensus Conference on Haemochromatosis. J Hepatol. 2000;33:485-486.
2. Powell LW, Subramaniam VN, Yapp TR. Haemochromatosis in the new millennium. J Hepatol. 1999;32(suppl 1):48-62.
3. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399.
4. Asberg A, Thorstensen K, Hveem K, et al. Hereditary hemochromatosis: the clinical significance of the S65C mutation. Genet Test. 2002;122:59-62.
5. Harrison SA, Bacon BR. Hereditary hemochromatosis: update for 2003. J Hepatol. 2003;38:14-23.
6. Adams P, Brissot P, Powell LW. EASL Internacional Consensus Conference on Haemochromatosis. J Hepatol. 2000;33:487-494.
7. Bacon BR, Powell LW, Adams PC, et al. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology. 1999;116:193-207.
8. Powell LW, Leggett BA, Crawford DHG. Hemochromatosis and other iron storage disorders. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's Diseases of the Liver, 8th ed. Philadelphia: Lippincott-Raven, 1999:1107-1130.
9. Niederau C, Fisher R, Sonnenberg A, et al. Survival and causes of death in cirrhotic and non-cirrhotic patients with primary hemochromatosis. N Engl J Med. 1986;313:1256-1262.
10. Bristol P, Moirand R, Guyader D, et al. Hemochromatosis after the gene discovery: revisiting the diagnostic strategy. J Hepatol. 1998;28:14-18.
11. Liberati A, Benhamou JP, Berg A, et al. EASL Internacional Consensus Conference on Haemochromatosis. J Hepatol. 2000;33:496-504.
12. Wilson JM, Junger G. The Principles and Practice of Screening for Disease [Public Health Paper 34]. Geneva: World Health Organization, 1968.
13. Tavill AS. Screening for hemochromatosis: phenotyping or genotyping or both? Am J Gastroenterol. 1999;94:1430-1433. Review.
14. McDonnell SM, Phatak PD, Felitti V, et al. Screening for hemochromatosis in primary care settings. Ann Intern Med. 1998;129:962-970.
15. Cullen LM, Summerville L, Glassick TV, et al. Neonatal screening to determine the population frequency of the haemochromatosis C282Y mutation. Blood. 1998;90:4236-4237.
16. Ryan E, Byrnes V, Flanagan A, et al. Haemochromatosis: an Irish disease [Abstract]. Hepatology. 1998;28:527.
17. Olynyk J, Cullen D, Rossi R, et al. Clinical expression of the hemochromatosis genotype Cys282Tyr in the Busselton population [Abstract]. Hepatology. 1998;28:528.
18. Adams PC, Kertesz AE, Barr R. Population screening for hemochromatosis with the unbound iron binding capacity [Abstract]. Gastroenterology. 1998;114:1199.
19. Sanchez M, Bruguera M, Bosch J, et al. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J Hepatol. 1998;29:725-728.
20. McLaren CE, McLachlan GJ, Halliday JW, et al. Distribution of transferrin saturation in na Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology. 1998;114:543-549.
21. Guyader D, Jacquelinet C, Moirand R, et al. Noninvasive prediction of fibrosis in C282Y homozygous haemochromatosis. Hepatology. 1995;22:1127-1131.
22. Bacon BR, Olynyk JK, Brunt EM, et al. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med. 1999;130:953-962.